R
4.67
0.30 (6.86%)
| 前收盘价格 | 4.37 |
| 收盘价格 | 4.38 |
| 成交量 | 230,683 |
| 平均成交量 (3个月) | 208,119 |
| 市值 | 216,326,800 |
| 价格/销量 (P/S) | 5.51 |
| 股市价格/股市净资产 (P/B) | 13.14 |
| 52周波幅 | |
| 利润日期 | 12 Nov 2025 |
| 营业毛利率 | -15.10% |
| 营业利益率 (TTM) | -12.92% |
| 稀释每股收益 (EPS TTM) | -0.120 |
| 季度收入增长率 (YOY) | 17.50% |
| 总债务/股东权益 (D/E MRQ) | 22.83% |
| 流动比率 (MRQ) | 2.44 |
| 杠杆自由现金流 (LFCF TTM) | 1.05 M |
| 资产报酬率 (ROA TTM) | -13.09% |
| 股东权益报酬率 (ROE TTM) | -29.87% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 混合的 | 看跌 |
| Medical Instruments & Supplies (全球的) | 混合的 | 看跌 | |
| 股票 | KORU Medical Systems, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
0.5
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.0 |
| 技术平均移动指标 | -1.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.50 |
|
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Core |
| 内部持股比例 | 7.65% |
| 机构持股比例 | 51.77% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 8.00 (Lake Street, 71.31%) | 购买 |
| 中 | 7.00 (49.89%) | |
| 低 | 6.00 (Canaccord Genuity, 28.48%) | 购买 |
| 平均值 | 7.00 (49.89%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 5.79 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Lake Street | 22 Dec 2025 | 8.00 (71.31%) | 购买 | 6.07 |
| Canaccord Genuity | 17 Dec 2025 | 6.00 (28.48%) | 购买 | 5.51 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合